Global Immunofluorescence Assay Market Research Report

 Based on the GME predictions, the Global Immunofluorescence Assay Market would grow with a CAGR value of 6.25%and cross USD 3.50 billion by 2026. Immunofluorescence Assay (IFA) is also known as a usual virologic technique used to identify the existence of antibodies in infected cells. The demand for Immunofluorescence Assay is indirectly related to the rate of diseases

Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on " Immunofluorescence Assay- Forecast to 2026" 

https://www.globalmarketestimates.com/market-report/global-immunofluorescence-assay-market-2790

By Product (Antibodies, Reagents, Kits, Instruments, Consumables, and Accessories), By Type (Indirect Immunofluorescence, Direct Immunofluorescence), By Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostics Centers), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

 Key Market Insights

·         An increase in chronic illness worldwide, especially during the COVID 19 pandemic required the use of Immunofluorescence Assay for testing antigens.

·         Support from various government schemes for promoting research and development

·         Various competitors in the Immunofluorescence market include Abcam plc, Werfen Company, Bio-Rad Laboratories, Inc, MaxVision Biosciences Inc, AESKU GROUP GmbH, Merck KGaA (Germany), Elabscience, Inc., EpiGentek Group, Cell Signaling Technology, Inc. (US), Abnova Corporation, MEDIPAN GmbH (Germany), J. Mitra& Co. Pvt. Ltd. (India), Sino Biological, Inc. (China), Cellabs (Australia), Danaher Corporation (US), Zyagen, Inc. (US), Agilent Technologies, Enzo Biochem, Inc. (US), Bruker Corporation, Becton, Dickinson, and Company (US), Thermo Fisher Scientific, Inc, Nikon Corporation, Olympus Corporation and PerkinElmer Inc amongst others..

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-immunofluorescence-assay-market-2790

Product Outlook (Revenue, USD Million, 2021-2026)

·         Antibodies

·         Reagents

·         Kits

·         Instruments

·         Consumables and Accessories

 

Type Outlook (Revenue, USD Million, 2021-2026)

·         Indirect Immunofluorescence

·         Direct Immunofluorescence

Disease Outlook (Revenue, USD Million, 2021-2026)

·         Cancer

·         Infectious Diseases

·         Cardiovascular Diseases

·         Autoimmune Diseases

·         Other Diseases

End-User Outlook (Revenue, USD Million, 2021-2026)

·         Academic & Research Institutes

·         Pharmaceutical & Biotechnology Companies

·         Contract Research Organizations

·         Hospitals & Diagnostic Centers

 

Regional Outlook (Revenue, USD Million, 2021-2026)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php